Everyone’s going on — and off — GLP-1s. What’s that doing to your health?

CBC - Oct 27, 2026

GLP-1s were designed and tested for long-term use, to combat chronic health conditions like diabetes and obesity. But what happens when you take these blockbuster weight loss drugs for a short stint? With more patients hopping on and off GLP-1s, scientists are trying to find out what that actually does to your body.

Read full article

More News

Oct 27, 2026

Holiday Travel Costs Are Soaring. Here’s How to Save.

As airfares and gas prices surge, here’s how you can extend your travel budget.

Oct 27, 2026

What is the Budget and what could be in it?

Chancellor John Healey will set out his plans for UK taxes on 28 October.

Oct 27, 2026

U.S. Pensions Are Riding the A.I. Wave. For Better or Worse.

As exuberance around the technology stokes fears of a bubble, the nation’s public pensions are starting to grapple with their role — and their risks.

Oct 27, 2026

In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank

Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.

Oct 27, 2026

Apple to replace iPhone Duos affected by screen problem

Photos shared online showed faults appearing on the screens of Apple's first foldable device.

Oct 27, 2026

In Anthropic I.P.O., Goldman and Morgan Stanley Slug It Out for Top Bank

Anthropic named the Wall Street firms lead underwriters on its upcoming public offering, a role that will generate generous fees and enormous prestige.

Oct 27, 2026

The Fed Is Expected to Hold Rates Steady. Warsh Will Have to Explain Why.

Inflation is moving in the wrong direction and the labor market remains stable, a combination that bolsters the case for higher interest rates.

Oct 27, 2026

Why Is Halloween Candy So Expensive?

The average cost of a 100-piece bag has jumped 71 percent in the last five years. Consumers are thinking twice about what they’ll spend.

Oct 27, 2026

In the A.I. ‘Robogym,’ Machines Train to Be More Like Humans

Germany’s Neura is one of the companies at the forefront of efforts to use artificial intelligence in robotics, and crucial to whether Europe can close the gap with China.